NanoViricides (NYSE: NNVC) reported a good safety profile of an optimized FluCide drug candidate in a GLP-like toxicology study in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE